Results 221 to 230 of about 5,240,088 (306)

Comparison between a chimeric anti-methamphetamine monoclonal antibody and humanized antibodies on pharmacological effects of methamphetamine. [PDF]

Psychopharmacology (Berl)
Berquist MD, Gunnell M, Henry R, Gentry WB, Stevens MW.   +4 more
europepmc   +1 more source

Comparative outcomes of HSCT with posttransplant cyclophosphamide in older adults: the impact of donor type. [PDF]

Blood Adv
Aljawai YM, Ramdial J, Smallbone P, Chen G, Kebriaei P, Pasvolsky O, Popat U, Oran B, Rezvani K, Champlin RE, Shpall EJ, Mehta RS.   +11 more
europepmc   +1 more source

Cannabis Use Moderates Methamphetamine- and HIV-Related Inflammation: Evidence from Human Plasma Markers. [PDF]

Viruses
Rogers JM, Chentsova VO, Wang CX, Marcondes MCG, Cherner M, Ellis RJ, Letendre SL, Heaton RK, Grant I, Iudicello JE.   +9 more
europepmc   +1 more source

The Quaker Poet in Community

, 2015
Jolliff, William
core  

Allogeneic hematopoietic stem cell transplantation for mixed-phenotype acute leukemia: a single-center study. [PDF]

Front Immunol
Hao M, Zhao X, Zhang X, Zhai W, Ma Q, Yang D, Pang A, Feng S, He Y, Jiang E, Han M.   +10 more
europepmc   +1 more source

Up-front alternative donor HCT in severe aplastic anemia: gaps and opportunities to translate evidence into practice. [PDF]

Blood Adv
Bhatt NS, Borogovac A, Efebera YA, DeSalvo A, Devine SM, Foley A, Greco-Stewart V, Hamilton BK, Heuer M, Molfenter T, Plastaras JP, Ragon BK, Wall SA, Broglie L, Juckett MB, Khera N, Horowitz MM, DeZern AE.   +17 more
europepmc   +1 more source

Anti-thymocyte globulin (ATG)- or alemtuzumab-based graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic hematopoietic cell transplantation (HCT) for patients 40 years and older with acute lymphoblastic leukemia in first complete remission: a study from the EBMT Acute Leukemia Working Party. [PDF]

Bone Marrow Transplant
Bug G, Labopin M, Byrne JL, Mielke S, Orchard K, Paneesha S, Potter V, Blaise D, Besley C, Snowden JA, Yakoub-Agha I, Clark A, Crawley C, Spyridonidis A, Sanz J, Brissot E, Giebel S, Ciceri F, Mohty M.   +18 more
europepmc   +1 more source

Impact of early tacrolimus exposure on outcomes after allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes. [PDF]

Ann Hematol
Jäger P, Ralfs AA, Schulz F, Liebers N, Bobak J, Baermann BN, Twarock S, Hölscher A, Nachtkamp K, Kasprzak A, Lavikka J, Matkey F, Watrin T, Yaouti ME, Germing U, Dietrich S, Kobbe G.   +16 more
europepmc   +1 more source

New age HCT conditioning regimens: what works and why? [PDF]

Hematology Am Soc Hematol Educ Program
Ali N, Sandmaier BM.
europepmc   +1 more source

Comparison of clinical outcomes between early and delayed allogeneic hematopoietic stem cell transplantation for severe aplastic anemia: a single-center retrospective study. [PDF]

Ann Hematol
Tan Z, Zhao Y, Hu H, Yu Q, Zhang Y, Hu T, Wu D, Ye B, Liu W.   +8 more
europepmc   +1 more source